U.S. federal trademark · Serial No. 78500335
Pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of disease and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.